ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,869Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 2170

$1.59M Total Retail Price of All Prescriptions

Rank: 18 out of 2170

586 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 586 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

27% of this provider’s 586 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 18,259 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 838 554 S3 1 7
FUROSEMIDE 799 606 2 6
SIMVASTATIN 740 595 3 1
OMEPRAZOLE 572 352 4 2
LEVOTHYROXINE SODIUM 565 465 5 5
LISINOPRIL 497 359 6 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 463 309 7 20
AMLODIPINE BESYLATE 397 352 8 4
GABAPENTIN 394 268 9 14
METOPROLOL TARTRATE 393 324 10 10
MELOXICAM 370 274 11 28
PANTOPRAZOLE SODIUM 354 289 12 39
ZOLPIDEM TARTRATE 352 190 13 17
CLOPIDOGREL 333 286 14 37
DONEPEZIL HCL 304 296 15 32
METOPROLOL SUCCINATE 276 197 16 13
CARVEDILOL 261 207 17 26
WARFARIN SODIUM 260 228 18 15
METFORMIN HCL 260 135 18 8
PRAVASTATIN SODIUM 257 195 20 11
SERTRALINE HCL 252 188 21 25
MIRTAZAPINE 244 233 22 46
ATORVASTATIN CALCIUM 239 164 23 12
HYDROCHLOROTHIAZIDE 236 143 24 9
PLAVIX 233 209 25 58
PREDNISONE 220 151 26 41
OXYCODONE-ACETAMINOPHEN 211 112 S2 27 60
GLIMEPIRIDE 200 160 28 31
NAMENDA 199 199 29 48
ADVAIR DISKUS 196 108 30 45
ESCITALOPRAM OXALATE 190 152 31 75
NEXIUM 190 182 31 22
POTASSIUM CHLORIDE 189 144 33 16
AMLODIPINE BESYLATE-BENAZEPRIL 186 133 34 67
PAROXETINE HCL 181 106 35 65
METFORMIN HCL ER 180 131 36 35
CRESTOR 179 171 37 24
SPIRIVA 177 147 38 49
CYMBALTA 174 96 39 44
DIOVAN 172 133 40 53
JANUVIA 172 117 40 80
TRAMADOL HCL 169 95 42 18
QUETIAPINE FUMARATE 160 113 43 88
ALLOPURINOL 160 123 43 29
CITALOPRAM HBR 159 134 45 19
LYRICA 158 116 46 90
TAMSULOSIN HCL 135 116 47 33
LANTUS 134 129 48 51
FENTANYL 131 79 S2 49 87
ZETIA 127 99 50 78
PROAIR HFA 126 71 51 43
NYSTATIN 125 122 52 160
DIGOXIN 121 109 53 72
PROMETHAZINE HCL 120 45 R 54 70
FENOFIBRATE 115 98 55 57
BUPROPION XL 114 60 56 170
TRAZODONE HCL 113 56 57 38
RAMIPRIL 110 100 58 77
AZITHROMYCIN 110 70 58 47
DIOVAN HCT 109 70 60 76
GLYBURIDE-METFORMIN HCL 109 56 R 60 154
CLONIDINE HCL 107 54 62 54
ATENOLOL 107 89 62 23
LOSARTAN POTASSIUM 102 91 64 21
ISOSORBIDE MONONITRATE ER 101 88 65 50
LOSARTAN-HYDROCHLOROTHIAZIDE 100 87 66 42
FAMOTIDINE 100 78 66 96
LIDODERM 96 81 68 162
SINGULAIR 95 57 69 85
CYCLOBENZAPRINE HCL 95 41 R 69 52
TRICOR 92 79 71 130
COLCRYS 91 71 72 140
KLOR-CON M20 91 84 72 68
LOVASTATIN 87 48 74 34
VYTORIN 86 74 75 179
SEROQUEL 85 68 76 168
ROPINIROLE HCL 83 61 77 92
DILTIAZEM 24HR CD 81 62 78 82
SPIRONOLACTONE 81 48 78 71
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 69 80 95
CEPHALEXIN 80 69 80 120
AGGRENOX 79 68 82 169
LIPITOR 79 54 82 83
HUMALOG 79 75 82 190
DILTIAZEM 24HR ER 77 53 85 135
LEXAPRO 76 68 86 198
RISPERIDONE 76 62 86 73
CELEBREX 75 60 88 89
AMITRIPTYLINE HCL 75 58 R 88 61
RANITIDINE HCL 74 73 90 40
LEVEMIR FLEXPEN 73 31 91 185
METHYLPREDNISOLONE 72 46 92 214
BUMETANIDE 72 58 92 191
CIPROFLOXACIN HCL 69 65 94 69
TOPIRAMATE 69 12 94 155
OXYCODONE HCL-ACETAMINOPHEN 68 21 S2 96 74
NOVOLOG 68 53 96 98
LEVOFLOXACIN 68 48 96 99
OXYCONTIN 67 20 S2 99 146
MONTELUKAST SODIUM 67 46 99 157
PEN NEEDLE 66 34 101 141
FLUOXETINE HCL 66 47 101 59
FINASTERIDE 65 53 103 122
POLYETHYLENE GLYCOL 3350 61 52 104 63
ABILIFY 60 47 105 159
PHENYTOIN SODIUM EXTENDED 60 37 105 142
VENTOLIN HFA 59 45 107 102
ONGLYZA 56 34 108 216
EXELON 56 56 108 119
NOVOLOG MIX 70-30 56 46 108 261
DOXYCYCLINE HYCLATE 54 30 111 100
PREMARIN 54 29 R 111 145
HYDROCODONE BIT-IBUPROFEN 54 0 S3 111 359
LAMOTRIGINE 54 14 111 136
SYNTHROID 52 52 115 27
LANTUS SOLOSTAR 51 43 116 79
INSULIN SYRINGE 51 38 116 113
AMPHETAMINE SALT COMBO 50 0 S2 118 321
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.